Skip to content Skip to menu

In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry

About Us

Papers, Reports & Submissions

Publications

Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

International Clinical Trials Day Media release

Today marks international Clinical Trials Day. It is a time to recognise the contribution clinical trials make to the global efforts to find discover and develop the latest breakthrough medicines and vaccines, as well as celebrating some remarkable advances in Australian medical science. Medicines Australia Chairman, MrWes Cook, said Medicines Australia members conduct around 600-700…

View article· Friday, 20 May 2016

Promise to reduce barriers to Clinical Trials will benefit patients

The Federal Government’s election commitment to better coordinate clinical trials is welcome news for patients, researchers and innovative medicine companies. Medicines Australia members conduct around 600-700 clinical trials nationally each year in partnership with hospitals, universities and other research institutions. These clinical trials provide Australian patients with early access to the latest potential breakthroughs in…

View article· Friday, 20 May 2016

Federal Budget 2016 – Commitment to the PBS

The innovative medicines industry acknowledges the Australian Government’s commitment to maintaining funding levels within the Federal Budget for the Pharmaceutical Benefits Scheme (PBS). The PBS is designed to ensure that Australian patients receive timely access to innovative medicines. “We believe tonight’s budget provides predictability in PBS arrangements, improvements to registration processes for new medicines coupled…

View article· Tuesday, 3 May 2016

Productivity Commission Draft Report on Intellectual Property Arrangements

Medicines Australia notes the release of the draft report from the Productivity Commission concerning Australia’s Intellectual Property (IP) arrangements. While the 400 page draft has only just been made available, we do have a number of concerns with the interim-findings which we believe may inadvertently lead to public misunderstanding of patents and IP as it…

View article· Friday, 29 April 2016

World Intellectual Property Day 2016

Medicines Australia acknowledges World Intellectual Property Day, an international initiative celebrating the role intellectual property plays in stimulating innovation. Medicines Australia represents the research-based innovative medicines industry in Australia. Our members invest more than $1 billion every year in Australian-based research and development such as clinical trials and partnerships with Australian Universities, Biotechs and research…

View article· Wednesday, 27 April 2016

Less red tape for Clinical Trials will benefit patients and researchers

Medicines Australia welcomes the announcement made by the nation’s Health Ministers in Perth to work towards a national framework for clinical trials. A new commitment was made by the COAG health council to identify more ways we can improve Australia’s attractiveness as a preferred destination for clinical trials. This type of reform is exactly what…

View article· Monday, 11 April 2016

Joint Media Release: Medicines sector reforms deliver consumer benefits and a sustainable PBS

Consumers, taxpayers and the national health system will benefit from the significant savings being delivered by medicine suppliers since 1 April. The direct contribution the medicine supply chain is making to these savings will ensure the PBS is sustainable into the future, enabling the reinvestment savings into the funding of new, breakthrough medicines for Australian…

View article· Monday, 4 April 2016

Pat Clear Award Winner 2016

The 2016 Pat Clear Award, has been won by Ms Zarli French, Senior Manager External Affairs at MSD. This prestigious award is presented annually to recognise outstanding contributions by those who work in the Australian medicines industry. Ms French has been working at MSD for 30 years. She is well known for her outstanding achievements…

View article· Friday, 1 April 2016

Interim CEO Appointed to Medicines Australia

The Board of Medicines Australia has appointed Mr Lee Hill to the role of Interim CEO. Mr Hill joins Medicines Australia with over 10 years of experience as a senior business leader, having held CEO and Managing Director roles in a number of leading companies and consultancies across Australia. Mr Wes Cook, Chair of Medicines…

View article· Thursday, 14 January 2016

Medicines Australia CEO

Medicines Australia CEO Tim James today announced his resignation effective January 2016 from the leadership role of the pharmaceutical sector peak body. Medicines Australia Interim Chairman Wes Cook thanked Tim for his strong contribution to the Australian medicines industry during a very difficult period for the sector: “Tim has been a passionate advocate for the…

View article· Saturday, 19 December 2015

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.


Social

Great initiative by @GSK_AU helping Australia's extraordinary talent in science and medical #research https://t.co/urxHdnAAKb

Coalition's plan to help fight rare teen cancer is welcome news for both innovative medicine manufacturers and patients #auspol

Congrats @KollingINST on being named #ClinicalTrialsDay #trialoftheyear for work on premature births. So important. https://t.co/Ob8cbzjWWp

RT @ACTAcommunity: .@MedicinesAus' Wes Cook: "We need to build stronger partnerships & support clinical trial ecosystem". #clinicaltrialsda

RT @PharmaDispatch: @MedicinesAus Chair Wes Cook #ClinicalTrialsDay - industry invests $1bn yearly in 600 trials in Aust #innovation https:…

Promise to reduce barriers to Clinical Trials will benefit patients https://t.co/YxYy3jn7V7

Looking fwd to @sussanley revealing Govt clinical trials election policy. Trials = early access to meds for patients https://t.co/Wahgrni06m

#clinicaltrialsday is a day to honour the hard work of researchers, doctors + nurses to bring new meds to patients. https://t.co/bIv0Zprq0a

RT @ACTAcommunity: Proud to be parterning with @MedicinesAus @AusBiotech & @ResAustralia to honour Australian clinical trials on #clinicalt

Report from pollies on all sides supporting investment in R&D + innovation eg. adv. manafac. + Uni collab. #auspol https://t.co/3UoQiCKzaH

Worth discussing the ideas in Joint Select Committee on Trade & Investment report on research & innovation. https://t.co/3UoQiCKzaH #Auspol